Brief: Daré Bioscience Announces Findings For The Treatment Of Menopausal Symptoms From A Phase 1/2 Clinical Trial Of DARE-HRT1 Intravaginal Rings
Aug 9 (Reuters) - Dare Bioscience Inc DARE.O :
* DARÉ BIOSCIENCE ANNOUNCES PUBLICATION IN THE JOURNAL OF
THE
NORTH AMERICAN MENOPAUSE SOCIETY OF POSITIVE EFFICACY FINDINGS
FOR THE TREATMENT OF MENOPAUSAL SYMPTOMS FROM A PHASE 1/2
CLINICAL TRIAL OF DARE-HRT1 INTRAVAGINAL RINGS
Source text for Eikon: ID:nGNX2PXlgx
Further company coverage: DARE.O
Recent news on Dare Bioscience
See all newsBrief: Dare Bioscience - Files For Resale Of Up To 8,934,345 Shares Of Common Stock - SEC Filing
Brief: Daré Bioscience CEO Sabrina Martucci Johnson Named To Forbes 2026 “50 Over 50 Innovation” List
NASDAQ RESUMED AT 12:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:45 PM
Dare Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary